bilaterals.org logo
bilaterals.org logo

Articles by language


TPP may be dead – but its impact lingers
Threats to affordable access to medicines continue unabated
India and Brazil conclude negotiations of Bilateral Investment Treaty
The conclusion of negotiations between India and Brazil culminating in a near-final treaty between the two nations.
EEU, Iran move closer to establishing free trade zone
Iran is one of the first countries the EEU wants to establish a free trade zone with, says Eurasian Economic Commission Chairman.
India, EU free trade pact talks stumble as bilateral investment treaties are set to lapse
New Delhi wants to re-negotiate all existing investment agreements
’New agreement to make the most of Jordan-US FTA’
An agreement will be signed on how to maximise benefits from the Jordan-US Free Trade Agreement
Australia pursues trade agenda in Asia
Australia Trade Minister is in Jakarta for talks over the Indonesia-Australia Comprehensive Economic Partnership Agreement
RCEP talks speed up amid TPP failure
Amid the collapse of the United States-backed Trans-Pacific Partnership (TPP) pact, trade officials from 10 Southeast Asian countries and six key partners started on Tuesday talks on a rival deal with new urgency.
The Indian government needs to answer crucial questions on the RCEP
Why is the Indian government signing the RCEP agreement, which allows foreign investors to sue governments, threatens access to life-saving medicines and puts at risk seed sovereignty?
Transition official: Trump will not rip up NAFTA
“I don’t think we’re looking to rip up NAFTA as much as we are looking to right-size it and make it fairer,” says senior advisor on the Trump transition team
On World AIDS Day, threat to access to medicines looms large
As trade negotiators from 16 countries gather in Indonesia to deliberate the terms of trade agreement — the Regional Comprehensive Economic Partnership agreement (RCEP), access to low-cost generic medicines is under grave threat.
Scrapping TPP won’t make a lick of difference
The problem with free trade deals is they rarely are about trade. In fact, trade usually is a side issue. And the TPP was a classic case in point.
Namur Declaration
The heated debates generated in Europe by the signature of the CETA have revealed that the way the EU negotiates international economic and trade agreements as well as their content are challenged by an increasingly large segment of public opinion.
Wallonia proposes new rules for negotiating international trade deals
Named after Namur, the capital of Wallonia, the declaration is signed by three dozen university professors from many countries, including the US and Canada.
EU closes in on TTIP-style deal with Japan
Officials in Brussels have announced that they are close to securing a free trade agreement with Japan.
India ready to resume BTIA talks with EU without preconditions
Government is committed to an early and balanced outcome of India-EU Bilateral Trade and Investment Agreement negotiations.
Asia should wrap up China-led trade talks quickly: ADB official
As the latest round of RCEP talks occur in Indonesia, ADB official says liberalisation of services are a challenge.
East Africa: Private sector to shape EPA deal
The Tanzania government will take the views of the private sector in deliberation of its position on the Economic Partnership Agreement between the European Union and the East African Community.
Netzpolitik editor: Trump will press on with ‘insidious’ TiSA deal
Net politics activist Markus Beckedahl argues that the proposed Trade in Services Agreement (TiSA) is a huge threat to data protection.
Wallonia threatens again to block CETA
The Walloon minister president Paul Magnette announced again that his region is ready to block the Comprehensive Economic and Trade Agreement (CETA) between the EU and Canada
MSF press release: RCEP trade deal negotiators must reject terms that would harm access to medicines
International medical humanitarian organisation Médecins Sans Frontières (MSF), along with other health groups, reiterated concerns about harmful intellectual property provisions in the proposed agreement that would increase market monopolies for pharmaceutical corporations and delay or block access to affordable generic medicines.